
Incorporating molecular classifications into radiotherapy treatment decisions for endometrial cancer patients can help identify those who will benefit from or can avoid unnecessary treatment.


coremsg

Radiotherapy decisions should be made using refined genomic guidance, as recommended by 2021 updated international guidelines, to better identify patients with molecularly aggressive disease.

How to Improve Radiotherapy Decisions in Endometrial Cancer

improving-radiotherapy-decisions-for-endometrial-cancer-patients-through-molecular-classification


Improving Radiotherapy Decisions for Endometrial Cancer Patients through Molecular Classification
